MyAverix Finance
SHG · Healthcare
Chengdu Easton Biopharmaceuticals Co Ltd (688513)
Biotechnology
Chengdu Easton Biopharmaceuticals Co Ltd (688513) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $11.72B, P/E ratio is 48.45, net margin is 21.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688513
Chengdu Easton Biopharmaceuticals Co Ltd (688513) — FAQ
What is Chengdu Easton Biopharmaceuticals Co Ltd's market cap?
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a reported market cap of $11.72B (data as of 2026-03-29).
What is 688513's P/E ratio?
The price-to-earnings (P/E) ratio for Chengdu Easton Biopharmaceuticals Co Ltd (688513) is 48.45 (data as of 2026-03-29).
Does Chengdu Easton Biopharmaceuticals Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Chengdu Easton Biopharmaceuticals Co Ltd (688513). Check the MyAverix Finance app for the latest dividend data.
What sector is Chengdu Easton Biopharmaceuticals Co Ltd in?
Chengdu Easton Biopharmaceuticals Co Ltd (688513) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688513 listed on?
688513 is listed on SHG.
What is Chengdu Easton Biopharmaceuticals Co Ltd's net margin?
Chengdu Easton Biopharmaceuticals Co Ltd (688513) reports a net margin of 21.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.